Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 12 Show results per page	View Search Criteria \| Help With Results


1.		Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				Not specified				Other				HSC-MS-06-0478 OSP-24412, NCT00581425

Last Modified: 1/7/2009 First Published: 2/27/2008


2.		Phase I/II Randomized Study of Cytomegalovirus-Specific T-Cell Adoptive Transfer in Patients With Newly Diagnosed Glioblastoma Multiforme Who Are Recovering From Therapeutic Temozolomide-Induced Lymphopenia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Biomarker/Laboratory analysis, Diagnostic, Treatment				Active				18 and over				NCI				DUMC-PRO00000580 PRO00000580, DUMC-SPORE Project 3, NCT00627224

Last Modified: 11/17/2008 First Published: 3/13/2006


3.		Phase II Randomized Study of Adjuvant gp100 Peptide Immunization With or Without Montanide ISA 51 and/or Imiquimod in Patients With Resected High-Risk Melanoma (Treatment Arms I-IV Closed to Accrual as of 1/11/08)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				16 and over				NCI				NCI-06-C-0069 7676, NCI-7676, NCI-P6703, NCT00304057


4.		Study of Immune Responses to Influenza Vaccination With or Without Imiquimod Application in Untreated CLL Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Active				Not specified				Other				Eudract number: 2006-004902-16 LREC number: 06/Q2201/143, NCT00596336


5.		Safety and Immunogenicity of CYT004-MelQbG10 Vaccine With and Without Adjuvant in Advanced Stage Melanoma Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				CYT004-MelQbG10 04 NCT00651703


6.		Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-Stimulating Factor (GM-CSF) and Imiquimod

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				NCI, Other				07-380 NCT00799110

First Published: 1/12/2009


7.		Phase II Study of Topical Imiquimod and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Patients With Advanced Stage Refractory Breast Cancer With Recurrent Chest Wall Disease or Cutaneous Metastases

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Approved-not yet active				18 and over				NCI				UWCC-6578 UWCC-6578, FHCRC-6578, IR-6578

First Published: 11/6/2008


8.		Phase I Study of pNGVL4a-Sig/E7(detox)/HSP70 DNA Vaccine and TA-HPV Vaccine With or Without Imiquimod in Patients With Human Papillomavirus 16-Positive Grade 3 Cervical Intraepithelial Neoplasia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Biomarker/Laboratory analysis, Prevention, Treatment				Active				18 and over				NCI				JHOC-J0656 J0656, NA_00002176, NCT00788164


9.		Viral Load Determination and Biomarkers of High Risk HPV-Types in HIV-Positive Men

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Natural history/Epidemiology, Treatment				Active				18 and over				Other				01 KI 0211 NCT00365729


10.		A Pilot Study of the Treatment of Facial Nodular and Nodulocystic Basal Cell Carcinoma With Double Curettage and Cautery Followed by Application of Imiquimod to the Base

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Treatment				Approved-not yet active				49 to 89				Other				WN07DE002 EudraCT No: 2007-001961-14, NCT00463359

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute